Salivary Gland Cancer

Our head and neck specialists are experienced in using highly technical procedures to remove salivary gland cancer while preserving or reconstructing important nerves. A team of experts, including ear, nose, and throat specialists called otolaryngologists, surgeons, radiation oncologists, and medical oncologists, works together to provide evidence-based, compassionate care. Rehabilitation experts manage any treatment-related side effects, and integrative medicine specialists offer services to support your overall wellbeing.

Clinical Trials and Research Studies

Phase 1

A Phase 1/1b Open-Label Multi-Center Study to Characterize the Safety and Tolerability of TRQ15-01 in Patients with Relapsed/Refractory Solid Tumors and Lymphomas

Learn More

Phase N/A

The AIM-HN and SEQ-HN Study: A 2 Cohort Non-comparative Pivotal Study Evaluating the Efficacy of Tipifarnib in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) with HRAS Mutations (AIM-HN) and the Impact of HRAS Mutations on Response to First Line Systemic Therapies for HNSCC (SEQ-HN)

Learn More

Phase 3

MK-3475 (SCH 9000475) as neoadjuvant and adjuvant therapy in Stage III-IVA resectable

Learn More

Phase 1

A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Learn More